NCT00024661View on ClinicalTrials.gov

Study to Determine the Maximum Tolerated Dose of LErafAON in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

October 31, 2004

Conditions
Neoplasms
Interventions
DRUG

LErafAON

Trial Locations (3)

19140

Temple University Cancer Center, Philadelphia

20007

Georgetown University, Washington D.C.

60637

University of Chicago Medical Center, Chicago

Sponsors
All Listed Sponsors
collaborator

Georgetown University

OTHER

lead

INSYS Therapeutics Inc

INDUSTRY